What's New Related to Drugs
More Email Subscriptions Related to Drugs
RSS Feed for This Page
Updated Monday through Friday
- CDER Launches New Accelerating Rare disease Cures (ARC) Program
- Drug Firm Annual Registration Status
- Drug Firm Annual Registration Status Download File
- National Drug Code Directory
- NDC Unfinished Drugs Excluded Database File
- NDC Database Excluded Packages and Products
- Wholesale Distributor and Third-Party Logistics Providers Reporting
August 7, 2023
- CDERLearn Training and Education (updated)
August 4, 2023
August 3, 2023
- Waivers, Exceptions, and Exemptions from the Requirements of Section 582 of the Federal Food, Drug, and Cosmetic Act
- Drug Trials Snapshots: FEXINIDAZOLE
- Drug Trials Snapshots: NEXTSTELLIS
- Drug Trials Snapshots: ZEGALOGUE
- FDA Drug Shortages
- Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets (Updated - Currently in Shortage)
- Azacitidine for Injection (New - Discontinuation)
- Azacitidine for Injection (Updated - Currently in Shortage)
- Difluprednate Ophthalmic Emulsion (Updated - Currently in Shortage)
- Linezolid Tablets (New - Discontinuation)
- Triamcinolone Acetonide Injectable Suspension (Updated - Currently in Shortage)
August 2, 2023
- Draft Guidance for Industry: Fixed-Combinations and Single-Entity Versions of Previously Approved Antiretrovirals for the Treatment or Prevention of Human Immunodeficiency Virus-One Under the President’s Emergency Plan for Acquired Immunodeficiency Syndrome Relief
- FDA approves trifluridine and tipiracil with bevacizumab for previously treated metastatic colorectal cancer
- FDA Drug Shortages
- Leucovorin Calcium Injection (Updated - Currently in Shortage)
- Methylphenidate Hydrochloride Extended Release Tablets (Updated - Currently in Shortage)
- Tirzepatide Injection (Updated - Currently in Shortage)
August 1, 2023
- Drugs@FDA Data Files (updated)
- CDER Conversation: Improving Medication Adherence and Patient Experience by Researching Patient Perceptions of Generic Drug
- FDA warns consumers that Tydemy, a prescription oral contraceptive, may have reduced effectiveness
- FDA Drug Shortages
- Bupivacaine Hydrochloride Injection (Updated - Discontinuation)
- Diclofenac Sodium Topical Gel (New - Discontinuation)
- Echothiophate Iodide (Phospholine Iodide) Ophthalmic Solution (Updated - Currently in Shortage)
- Isoniazid Injection (Updated - Currently in Shortage)
- Multi-Vitamin Infusion (Adult and Pediatric) (Updated - Currently in Shortage)
- Pramipexole Dihydrochloride Extended Release Tablets (New - Discontinuation)
July 31, 2023
July 28, 2023
- Conference/Workshop - Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2023
- CDER collaborates with global regulators on pharmaceutical quality assessments and inspections
- FDA Drug Shortages
- Cisplatin Injection (Updated - Currently in Shortage)
- Methotrexate Injection (Updated - Currently in Shortage)
- Somatropin Injection (Updated - Currently in Shortage)
July 27, 2023
- Competitive Generic Therapy Approvals (updated)
- Drug Trials Snapshots: QULIPTA
- FDA Drug Shortages
- Indigotindisulfonate Sodium Injection (Updated - Currently in Shortage)
July 26, 2023
- Final Guidance: CDER’s Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality
- Activities Report of the Generic Drug Program | FDARA Title VIII Sections 807 and 805 (updated)
- Prescription Stimulant Medications
- FDA Drug Shortages
- Methylphenidate Hydrochloride Extended Release Tablets (New - Currently in Shortage)
July 25, 2023
- Drugs@FDA Data Files (updated)
July 24, 2023
- Event - OTC Monograph Reform: OMOR Format and Content & Electronic Submissions
- Event - Advancing Generic Drug Development: Translating Science to Approval 2023
- CURE ID, A Tool for Clinicians to Report New Uses of Existing Drugs with Heather Stone and Dr. Marco Schito
- FDA Drug Shortages
- Bupivacaine Hydrochloride Injection (Updated - Currently in Shortage)
- Dexamethasone Sodium Phosphate Injection (Updated - Currently in Shortage)
- Etomidate Injection (Updated - Currently in Shortage)
- Fluorescein Injection (Updated - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
- Methotrexate Tablets (Updated - Currently in Shortage)
- Vecuronium Bromide for Injection (Updated - Currently in Shortage)
July 21, 2023
- Drug Trials Snapshots: LEQVIO
- FDA Drug Shortages
- Beclomethasone Dipropionate Monohydrate Nasal Spray (New - Discontinuation)
- Lidocaine Hydrochloride (Xylocaine) Injection (New - Currently in Shortage)
- Methamphetamine Hydrochloride Tablets (Updated - Currently in Shortage)
- Methotrexate Tablets (New - Currently in Shortage)
- Potassium Acetate Injection (Updated - Currently in Shortage)
July 20, 2023
- Drug Trials Snapshots: ZYNLONTA
- FDA Drug Shortages
- Furosemide Injection (Updated - Currently in Shortage)
- Metronidazole Injection (Updated - Currently in Shortage)
July 19, 2023
- FDA Drug Shortages
- Carboplatin Injection (New - Currently in Shortage)
July 18, 2023
- Drugs@FDA Data Files (updated)
- GDUFA Implementation Quarterly Meetings between FDA and Industry (updated)
- Competitive Generic Therapy Approvals
- Drug Trials Snapshots: SAPHNELO
- FDA Drug Shortages
- Amino Acids (Updated - Currently in Shortage)
- Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets (Updated - Currently in Shortage)
- Lorazepam Injection (New - Discontinuation)
July 17, 2023
- FDA Drug Shortages
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
- Lorazepam Injection (Updated - Currently in Shortage)
- Multi-Vitamin Infusion (Adult and Pediatric) (Updated - Currently in Shortage)
- Rocuronium Bromide Injection (Updated - Currently in Shortage)
- Sodium Phosphates Injection (Updated - Currently in Shortage)
- Novel Drug Approvals for 2023 (updated)
July 14, 2023
- FDA Drug Shortages
- Lisdexamfetamine Dimesylate Capsules (New - Currently in Shortage)
- Orange Book
- Orange Book Current Cumulative Supplement (updated)
- Additions/Deletions for Prescription and OTC Drug Product Lists (updated)
- Orange Book Data Files (compressed) (updated)
- Reference Listed Drugs by ANDA Reference Standard List (updated)
- Orange Book Patent Listing Dispute List (updated)
- Appendix A: Product Name Index (updated)
- Appendix B: Product Name Sorted by Applicant (updated)
- Appendix C: Uniform Terms (updated)
July 13, 2023
- FDA Drug Shortages
- Edetate Calcium Disodium Injection (New - Currently in Shortage)
- Methotrexate Injection (Updated - Currently in Shortage)
July 12, 2023
- FDA Drug Shortages
- Diazepam Rectal Gel (Updated - Currently in Shortage)
- Flurazepam Hydrochloride Capsules (Updated - Currently in Shortage)
- Methylprednisolone Acetate Injection (New - Currently in Shortage)
- Rivaroxaban Oral Suspension (Updated - Resolved)
July 11, 2023
- Drugs@FDA Data Files (updated)
- FDA Drug Shortages
- Cisplatin Injection (Updated - Currently in Shortage)
- Memantine Hydrochloride Extended Release Capsules (New - Discontinuation)
- Memantine Hydrochloride Tablets (New - Discontinuation)
- Sincalide (Kinevac) Lyophilized Powder for Injection (Updated - Resolved)
- SBIA Chronicles: Insights About the FDA/EMA Parallel Scientific Advice Program for Complex Generic/Hybrid Drug Products
- Draft Guidance: Inborn Errors of Metabolism That Use Dietary Management: Considerations for Optimizing and Standardizing Diet in Clinical Trials for Drug Product Development
- Using Patient-Reported Outcomes to Measure Frailty in Patients with Multiple Myeloma (updated)
July 10, 2023
- Drug Trials Snapshot: TAVNEOS
- FDA Drug Shortages
- Atropine Sulfate Injection (Updated - Currently in Shortage)
- Bupivacaine Hydrochloride and Epinephrine Injection (Updated - Currently in Shortage)
- Bupivacaine Hydrochloride Injection (Updated - Currently in Shortage)
- Clindamycin Phosphate Injection (Updated - Currently in Shortage)
- Dexmedetomidine Injection (Updated - Currently in Shortage)
- Dextrose 25% Injection (Updated - Currently in Shortage)
- Dextrose 50% Injection (Updated - Currently in Shortage)
- Disopyramide Phosphate (Norpace) Capsules (Updated - Currently in Shortage)
- Dobutamine Hydrochloride Injection (Updated - Currently in Shortage)
- Dopamine Hydrochloride Injection (Updated - Currently in Shortage)
- Epinephrine Injection, 0.1 mg/mL (Updated - Currently in Shortage)
- Etomidate Injection (Updated - Currently in Shortage)
- Fentanyl Citrate (Sublimaze) Injection (Updated - Currently in Shortage)
- Gentamicin Sulfate Injection (Updated - Currently in Shortage)
- Heparin Sodium and Sodium Chloride 0.9% Injection (Updated - Currently in Shortage)
- Hydrocortisone Sodium Succinate Injection (Updated - Currently in Shortage)
- Hydromorphone Hydrochloride Injection (Updated - Currently in Shortage)
- Ketamine Injection (Updated - Currently in Shortage)
- Ketorolac Tromethamine Injection (Updated - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
- Mannitol Injection (Updated - Currently in Shortage)
- Metronidazole Injection (Updated - Currently in Shortage)
- Midazolam Injection (Updated - Currently in Shortage)
- Pantoprazole Sodium for Injection (Updated - Currently in Shortage)
- Penicillin G Benzathine Injectable Suspension (Updated - Currently in Shortage)
- Potassium Acetate Injection (Updated - Currently in Shortage)
- Rocuronium Bromide Injection (Updated - Currently in Shortage)
- Sodium Acetate Injection (Updated - Currently in Shortage)
- Sodium Bicarbonate Injection (Updated - Currently in Shortage)
- Sodium Chloride 14.6% Injection (Updated - Currently in Shortage)
- Sodium Chloride 23.4% Injection (Updated - Currently in Shortage)
- Sodium Phosphates Injection (Updated - Currently in Shortage)
- Somatropin Injection (Updated - Currently in Shortage)
- Sterile Water for Injection (Updated - Currently in Shortage)
- List of Determinations Including Written Request (updated)